CSBR:NASDAQ
Champions Oncology Inc
4,70 USD
arrow_upward
+1,18%(+0,055) 1D
13-ноя., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,57 USD
High
4,70 USD
Low
4,52 USD
Mkt. cap
65,49 млн
Avg. vol.
8,16 миң
Volume
3,02 миң
52-wk high
8,31 USD
52-wk low
4,52 USD
EPS
-0,08 USD
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
Open
4,57 USD
High
4,70 USD
Low
4,52 USD
Mkt. cap
65,49 млн
Avg. vol.
8,16 миң
Volume
3,02 миң
52-wk high
8,31 USD
52-wk low
4,52 USD
EPS
-0,08 USD
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
News stories
From web sources and news partners
TradingView
·
1 саат мурун
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
TradingView
·
1 саат мурун
SpaceX's S&P 500 bid gets new life as Elon Musk pitches Tesla merger
The Motley Fool
·
3 саат мурун
Warren Buffett's Berkshire Compounded at More Than 19% a Year Over Six Decades, Nearly Double the S&P 500's 10% Return. Can Investors Still Apply That Playbook Today?
Traders Union
·
1 саат мурун
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersХаккенсак, Нью Джерси, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Websitechampionsoncology.com